Stellantis, the worldwide automaker that owns Chrysler, Jeep, and Ram, mentioned it's going to make investments $13 billion to beef up its U.S. manufacturing over the following 4 years as a part of...
Offers and Financings Beijing’s BeiGene (BGNE; HK: 06160; SHA: 688235) acquired international rights to a preclinical novel cyclin-dependent kinase 2 (CDK2) inhibitor from Boston’s Ensem Therapeutics in a $1.3 billion...
